At the baby
For babies, it is important to note that Umckaloablo® drops should not be taken until 12 months of age, as the effect on babies has not been clearly studied. There is Umckaloablo® juice especially for children. The dosage is 2.5 ml in the morning, at noon and in the evening for children over one year of age.
Active substances/ingredients
The active ingredients in Umkaloabo extract are catechin tannins, curmarines, flavonoids, polysterols and essential oils.
Effect
Antibacterial effect:According to current studies, Umckaloabo extract can prevent bacteria from attaching to mucosal cells. The phenol groups of the extract are probably responsible. Furthermore, Umckaloabo is supposed to prevent or slow down the reproduction of bacteria by stimulating the immune system.
Antiviral effect: Umckaloabo prevents viruses from attaching themselves to the mucosal cells and from multiplying viruses that have already penetrated the tissue. Mucolytic effect:It is observed that the extract also has an expectorant effect. The cause of the effect is still unclear.
Dosage
Adults and children over 12 years of age should take 20-30 drops 3 times a day for acute infections. For subsequent treatment, especially in chronic disease or frequent relapses, 10-20 drops 3 times daily. Children aged 6-12 years.
In case of acute infections 10-20 drops 3 times a day. Children under 6 years of age. Depending on age, 5-10 drops 3 times daily.
Side effect
Overall, side effects are rare. It should be noted that Umckaloabo is composed of various active ingredients such as coumarin (related to marcumar), phenols, silica and calcium and may, under certain circumstances, influence blood clotting through the action of coumarin. In 2011, the Drug Commission of German Pharmacists warned against the over-the-counter drug Umckaloablo®.
It said that taking it could lead to liver damage. However, this suspicion could not be clearly substantiated by studies. Nevertheless, since 2014, pelargonium-containing drugs such as Umckaloablo® have had to indicate the risk of liver damage. The package insert lists an increase in liver values as a side effect and reports cases of hepatitis and liver damage associated with the use of pelargonium-containing drugs. However, the frequency is unknown
